Understanding the Potential Drug Target and Biomarker Status of CYP4F26P

Target Name: CYP4F26P

NCBI ID: G106478958

Other Name(s): cytochrome P450 family 4 subfamily F member 26, pseudogene | Cytochrome P450 family 4 subfamily F member 26, pseudogene

Understanding the Potential Drug Target and Biomarker Status of CYP4F26P

CYP4F26P, also known as cytochrome P450 family 4 subfamily F member 26, is a gene that encodes a protein known as CYP4F26P. This gene is a member of the cytochrome P450 family, which is a large gene family that plays a crucial role in the metabolism of various drugs and other compounds. CYP4F26P is one of the genes within this family that has been identified as a potential drug target or biomarker.

The cytochrome P450 family consists of four subfamilies, each of which is characterized by a different gene locus. CYP4F26P is a member of the subfamily F, which is characterized by a specific gene locus that is located on chromosome 13. CYP4F26P is a pseudogene, which means that it is a genetic copy of a gene that does not code for any functional protein.

The CYP4F26P gene is expressed in many different tissues and cells throughout the body. It is primarily expressed in the liver, where it is involved in the metabolism of a wide variety of drugs and other compounds. CYP4F26P is also expressed in other tissues, including the kidney, heart, and intestine.

CYP4F26P is involved in the metabolism of many different drugs, including statins, antidepressants, and opioids. It is also involved in the metabolism of many other compounds, including drugs that are used to treat a wide range of medical conditions. For example, CYP4F26P is involved in the metabolism of the drug simvastatin, which is used to treat high cholesterol.

CYP4F26P is also involved in the regulation of the production of other proteins, which is important for the function of many different tissues and organs. For example, CYP4F26P is involved in the production of adenosine, which is a hormone that helps to regulate sleep and immune responses.

In addition to its role in drug metabolism, CYP4F26P is also involved in the regulation of the immune system. It is expressed in the skin and other tissues, and it is involved in the production of cytokines, which are proteins that are involved in the immune response.

CYP4F26P is also involved in the regulation of cellular signaling pathways, which are important for the function of many different cells and tissues. For example, CYP4F26P is involved in the regulation of the production of nitric oxide, which is a molecule that helps to relax blood vessels and improve blood flow.

The potential drug target status of CYP4F26P is based on its involvement in the metabolism of drugs and other compounds. However, it is also possible that CYP4F26P may be a biomarker for the development of certain diseases. For example, CYP4F26P may be involved in the regulation of the production of certain viruses, such as the flu.

In conclusion, CYP4F26P is a gene that encodes a protein that is involved in the metabolism of drugs and other compounds. It is a pseudogene that is expressed in many different tissues and cells throughout the body. In addition to its role in drug metabolism, CYP4F26P is also involved in the regulation of the immune system and cellular signaling pathways. The potential drug target and biomarker status of CYP4F26P is based on its involvement in these functions, but it is also possible that it may be involved in the regulation of the production of certain viruses. Further research is needed to fully understand the role of CYP4F26P in the body.

Protein Name: Cytochrome P450 Family 4 Subfamily F Member 26, Pseudogene

More Common Targets